ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,292Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 244

$778K Total Retail Price of All Prescriptions

Rank: 19 out of 244

400 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

12% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 14,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 788 769 1 3
LEVOTHYROXINE SODIUM 674 644 2 4
WARFARIN SODIUM 597 422 3 8
OMEPRAZOLE 439 413 4 6
POLYETHYLENE GLYCOL 3350 394 381 5 33
METOPROLOL TARTRATE 343 329 6 5
METOPROLOL SUCCINATE 343 343 6 11
LISINOPRIL 325 284 8 7
CYMBALTA 311 311 9 56
CITALOPRAM HBR 297 277 10 15
GABAPENTIN 292 237 11 14
DONEPEZIL HCL 257 256 12 9
LANTUS 254 232 13 30
SIMVASTATIN 238 208 14 1
SERTRALINE HCL 235 235 15 22
AMLODIPINE BESYLATE 204 204 16 2
LEVOFLOXACIN 201 194 17 111
CARBIDOPA-LEVODOPA 184 184 18 41
NAMENDA 184 184 18 19
ISOSORBIDE MONONITRATE ER 179 170 20 44
MIRTAZAPINE 175 175 21 13
CEPHALEXIN 175 173 21 107
PREDNISONE 172 171 23 43
TAMSULOSIN HCL 168 165 24 20
QUETIAPINE FUMARATE 164 143 25 31
IPRATROPIUM-ALBUTEROL 145 141 26 54
HYDROCODONE-ACETAMINOPHEN 139 137 S3 27 46
LEVETIRACETAM 133 120 28 39
ATENOLOL 128 128 29 18
KLOR-CON M20 127 126 30 98
HYDROCHLOROTHIAZIDE 126 126 31 12
VENLAFAXINE HCL ER 120 120 32 137
ADVAIR DISKUS 117 116 33 40
DILTIAZEM 24HR CD 116 116 34 136
NOVOLOG 113 106 35 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 102 36 125
TAMIFLU 104 99 37 99
FINASTERIDE 101 98 38 52
TRAVATAN Z 99 99 39 116
POTASSIUM CHLORIDE 98 73 40 25
ESCITALOPRAM OXALATE 97 86 41 60
LOSARTAN POTASSIUM 97 97 41 16
PANTOPRAZOLE SODIUM 95 95 43 61
METFORMIN HCL 83 57 44 10
PHENYTOIN SODIUM EXTENDED 83 71 44 190
RANEXA 82 82 46 312
OLANZAPINE 81 81 47 85
SPIRONOLACTONE 80 77 48 78
OXYBUTYNIN CHLORIDE ER 76 74 49 161
JANUVIA 74 74 50 32
FLUOXETINE HCL 74 74 50 132
GENERLAC 73 73 52 279
TRAMADOL HCL 73 73 52 53
ATORVASTATIN CALCIUM 73 66 52 17
DOXYCYCLINE HYCLATE 71 64 55 252
PRAVASTATIN SODIUM 70 52 56 47
DIOVAN 70 58 56 37
LAMOTRIGINE 68 68 58 225
DIGOXIN 68 68 58 45
BUMETANIDE 67 64 60 263
ALLOPURINOL 66 65 61 57
FAMOTIDINE 65 65 62 49
LIDODERM 64 64 63 69
TIMOLOL MALEATE 61 61 64 276
ROPINIROLE HCL 60 60 65 183
SEROQUEL 59 54 66 92
FLUTICASONE PROPIONATE 59 58 66 67
CLOTRIMAZOLE-BETAMETHASONE 56 50 68 117
SPIRIVA 56 55 68 66
NYSTATIN 55 55 70 83
GLIPIZIDE 55 50 70 42
DIVALPROEX SODIUM 55 45 70 59
CIPROFLOXACIN HCL 54 52 73 68
LATANOPROST 54 54 73 79
TRAZODONE HCL 54 53 73 35
HYDRALAZINE HCL 53 53 76 50
PAROXETINE HCL 53 41 76 95
MORPHINE SULFATE 51 50 S2 78 381
CARVEDILOL 51 50 78 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.